Search For "molecular"
Study predicts distribution of molecules using MXene magnetoresistance pro
Updated : 2 years, 5 months ago IST
Researchers have created a method to anticipate the distribution of molecules on the surface using the magnetoresistance feature of MXene.
Read More
Metropolis Healthcare successfully hosts the 25th IAP-ID Annual CME on “Cu
Updated : 2 years, 6 months ago IST
Mumbai (Maharashtra) [India], September 12: Metropolis Healthcare Limited, India's leading diagnostic service provider, hosted the 25th International Academy of Pathology – Indian Division (IAP-ID) Annual CME event in collaboration with the Asian Cancer Institute & Indian Medical Associa
Read More
Anti-leishmaniasis drugs change host cells at molecular level: Study
Updated : 5 months, 1 week ago IST
Researchers have proven the efficacy of vaccines they created to prevent the disfiguring skin illness leishmaniasis in animal experiments, and the most promising candidate is currently undergoing preparation for a Phase 1 human trial.
Read More
First line of defence against deadly ToCSV tomato virus explored
Updated : 2 years, 6 months ago IST
For the first time, scientists at the University of Johannesburg (UJ) have examined the molecular genetics of tomato plants' defence mechanisms against a destructive "young" Southern African virus. The well-known tomato yellow leaf curl virus (TYLCV) is known to be resistant to individuals
Read More
Study sheds more light on key link to autism spectrum disorder
Updated : 2 years, 7 months ago IST
Mayo Clinic and Yale University scientists determined that the origins of autism spectrum disorder may be related to an imbalance of particular neurons that play a vital role in how the brain communicates and works using human "mini-brain" models known as organoids. The cells in question are
Read More
Study sheds light on immunotherapy treatment for ALS
Updated : 5 months, 1 week ago IST
A type of monoclonal antibody that has already been tested in cancer may be a viable treatment for amyotrophic lateral sclerosis, or ALS, a fatal neurological disease.
Read More
Study gives more insight into immunotherapy treatment for ALS
Updated : 2 years, 7 months ago IST
A type of monoclonal antibody that has already been tried in certain types of cancer may be a viable treatment for amyotrophic lateral sclerosis, or ALS, a fatal neurological illness.
Read More
Study sheds light on molecular mechanisms of HIV drug resistance
Updated : 5 months, 1 week ago IST
Dolutegravir is one of the most potent antiviral drugs now being used in clinical practise to treat HIV. Scientists from the Salk Institute and the National Institutes of Health have discovered the molecular routes through which the human immunodeficiency virus (HIV) develops resistance to i
Read More
Scientists revive worm frozen 46,000 years ago
Updated : 2 years, 7 months ago IST
The roundworm, of a previously unknown species, survived 40 meters (131.2 feet) below the surface in the Siberian permafrost in a dormant state known as cryptobiosis, according to Teymuras Kurzchalia, professor emeritus at the Max Planck Institute of Molecular Cell Biology and Genetics in Dr
Read More
Study reveals how bromide ions cause ripples in semiclathrate hydrates
Updated : 2 years, 7 months ago IST
Understanding and maximising the characteristics of proton-conducting materials depends greatly on how water molecules behave in these materials
Read More
Researchers uncover molecular mechanisms of HIV drug resistance
Updated : 2 years, 7 months ago IST
Researchers from the Salk Institute and the National Institutes of Health have identified the molecular pathways by which the human immunodeficiency virus (HIV) develops resistance to dolutegravir, one of the most potent antiviral medications now being used in clinical use to treat HIV.
Read More
HIV drug resistance mechanisms revealed by protein structures: Study
Updated : 5 months, 1 week ago IST
Researchers from the Salk Institute and the National Institutes of Health have identified the molecular pathways by which the human immunodeficiency virus (HIV) develops resistance to dolutegravir, one of the most potent antiviral medications now being used in clinical use to treat HIV.
Read More